Atlas Trials

Immunogenicity and Safety of Two Lots of NBP608 Compared to Zostavax in Healthy Adult Aged 50 and Over

Clinical trial NCT03116594 · COMPLETED

Trial details

NCT number
NCT03116594
Sponsor
SK Chemicals Co., Ltd.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2014-01-03
Primary completion
2014-04-08
Enrollment
675

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.